European Diagnostic Manufacturers Association

EDMA Presentation 2007

Jean-François de LavisonPresident of EDMAMérieux Alliance

Geneva, Retooling Task ForceJanuary, 2008

2 Geneva, January 2008

European Healthcare Market in 2007

In Vitro Diagnostics 3.5%

Radiological, Electro-medical & Healthcare IT3.5%

Medical Devices25%

Pharmaceuticals68%

3 Geneva, January 2008

EDMA Members 30 Corporate Associated Members From 15 to 30

2006CellestisChironGenzymeTosoh2007 BiosystemsFIND DiagnosticsInnogeneticsLuminexMallinkrodtMLTOrionRandoxSiemens DiagnosticsSTAGO TECANPhilips

4 Geneva, January 2008

EDMA Members 21 National Association Members

Working to develop new IVD associations

From 20 to 21

2007 Turkey

5 Geneva, January 2008

EDMA Mission

To raise awareness of the added-value that diagnostic information can provide to health,

To support an appropriate regulatory system,

To work towards a realistic economic environment for healthcare, and

To be an effective voice in globalisation.

Advocating the value of IVDs

European Diagnostic Manufacturers Association

7 Geneva, January 2008

The essential role of IVDs

DISEASE

Diagnosis Therapy Prevention

Screening targeted populations

» Correct and early diagnosis is the key to effective & sustainable healthcare in the medium-long term.

IVDs represent less than 2% of the Total Health Expenditure, which is less than €20 per capita and per annum (EDMA 2005 European Market Estimates) and its information influences about 64% of the medical decisions (JD. Kruse-Jarrest, Lab. Med. 18:213/1994)

EDMA is campaigning to present laboratory testing as a valuable asset that is a cost-effective component of health maintenance and disease management.

Early & Correct Diagnosis is key to effective therapy

IVDs provide objective information in evaluating the

effects of treatment

8 Geneva, January 2008

Example: Tuberculosis

Clinical Benefit

New IVD tests offer, for the first time, the opportunity to stop TB infection before it progresses to disease.

IVDs allows an earlier detection of the pathogen agent, an earlier start of an adapted treatment, and in most of the cases an earlier recovery.

Economic Benefit

Direct economic impact of tuberculosis in the EU is estimated to be more than €1 billion.

Treatment of MDR-TB requires up to 2 years of chemotherapy, which is more than 100 times more expensive than treatment of drug-susceptible TB

Patient Benefit Faster diagnosis means

patients can be better managed at an earlier stage, resulting in

Europe has the highest rate of multidrug-resistant tuberculosis (MDR-TB) in the world, with nearly 70,000 cases per year. Virtually untreatable strains are emerging in Eastern Europe.

better control of the spread of TB,

avoidance of unnecessary suffering of patients, and their families/carers

more efficient utilisation of hospital resources

Draft messages: Work in progress

9 Geneva, January 2008

Mar 07, Brussels: ECDC Scientific Seminar» EDMA represented IVD sector interests» Contacts established with WHO, Stop TB Partnership, ECDC, etc.

Follow-up Meetings with all stakeholders» Objective: Discuss common actions to define and implement appropriate measures to fight TB

27-28 Sep 07, Lisbon: Portuguese Presidency Conference on ‘Health & Migration’- EDMA to attend and propose participation

22 October 2007, Berlin: High Level Ministerial Forum “TB is a regional emergency”» Organised by WHO-Europe, in cooperation with the EU,

ECDC, Stop TB Partnership, among other stakeholders- EDMA to attend and propose a speaker- Provide input for the future WHO TB Action Plan for Europe

TB Advocacy Actions

10 Geneva, January 2008

Soon available

in Italian 18-19 June, Turin

in Hungarian September

+ Global access to all sites

Lab Tests Online

Spain: www.LabTestsOnline.es

Germany: www.LabTestsOnline.de

Poland: www.LabTestsOnline.pl

Combined Traffic: Over 35,000 unique

visitors in May

Also available in the future in Portugueseand Czech

EDMA represents the In Vitro Diagnostics Industry in Europe Visit our website: www.edma-ivd.be

Place des Maïeurs 21150 Brussels

Belgium Tel +32 2 772 22 25

Fax +32 2 772 23 29 edma@edma-ivd.be

European Diagnostic Manufacturers Association